IL6 and congenital rubella syndrome: scale, but grade 3 using the UPenn scale.73 Moreover, increasing clinical experience in the early recognition and management of CRS and neurotoxicity is likely to reduce the incidence of severe toxicities, the early introduction of anti‐IL‐6 therapy and corticosteroids being associated with lower rates of life‐threatening complications.74